Developer docs
API playgroundTry for free, no card

Search company profiles

Satelia

Full company profile

uuid000294q

Namestring
Satelia
Legal namestring
NP Medical
Websiteurl
satelia.eu
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Satelia is a French digital health company that operates a remote patient monitoring platform purpose-built for chronic heart failure. Its core product, Satelia® Cardio, is a CE-marked Class IIa medical device software that uses structured symptom-based questionnaires — rather than connected devices or wearable sensors — to monitor patients weekly, with results processed by a proprietary algorithm that has demonstrated a 99.43% negative predictive value in identifying low-risk patients in the multicenter TELESAT-HF study. Approximately 77% of monitored patients self-report via a web application, while the remaining 23% are reached by telephone through Télesphore, an in-house paramedical and medical team of nurses, physicians, and medical secretaries that addresses digital exclusion among elderly and non-technophile patients (median patient age 73, over 50% aged 75+).

The company generates revenue via monthly operator fees (forfait opérateur) billed to French healthcare institutions under the national telemonitoring reimbursement framework (Sécurité Sociale), at the TVB rate of €28/patient/month for heart failure. The solution is sold exclusively through institutional channels — hospitals, cardiology practices, and university hospitals — via direct enterprise engagement and through the UniHA and Resah public procurement catalogs. Satelia is trusted by 500+ care providers including approximately one-third of French university hospitals and monitors 11,000+ patients nationwide. Clinical validation includes a 36% reduction in all-cause mortality demonstrated in the TELESAT-HF real-world study and an 87% patient satisfaction rate across 825 monitored patients.

Founded in 2017 by anesthesiologist-intensivist Nicolas Pagès and incorporated as NP Medical (société par actions simplifiée), Satelia is headquartered in Bordeaux. The company raised €10 million from Impact Partners in October 2022 to fund algorithm development and European expansion, obtained CE Class IIa marking in 2025, and has signaled European geographic expansion as a core strategic priority, supported by a December 2024 migration of data hosting to OVHcloud for European data sovereignty.

Short descriptiontext

Satelia is a French digital health company operating Satelia® Cardio, a CE-marked Class IIa remote patient monitoring platform for chronic heart failure patients. It combines a symptom-based algorithm with a human nurse support team (Télesphore) to serve 500+ French healthcare providers and 11,000+ patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBordeaux, France
HQ citystring
Bordeaux
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, heart failure telemonitoring, medical device software, chronic disease management, cardiac care coordination
Industry4 codes
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALABAD
Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALACAB
24/7 Nurse Line, Symptom Checker & Triage (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLACAGAG
Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
NAICS code2 codes
  • Home Health Care Services62161
  • Telephone Call Centers56142
SIC code2 codes
  • Services-Health Services8000
  • Services-Home Health Care Services8082
Product category
Remote Patient Monitoring Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Healthcare Reimbursement (French National Health Insurance)
TypeSubscription Recurring
Description

Satelia Cardio is reimbursed through the French national health insurance system (Sécurité Sociale). It is covered at 100% for patients with exemption from copayment (ticket modérateur) and at 60% under standard coverage. Specific rates apply for certain special regimes. Revenue is generated through operator fees billed monthly to healthcare facilities under the national telemonitoring framework.

satelia.eu
2Healthcare Cost Savings (Social Entrepreneurship Model)
TypeManaged Services
Description

Satelia is financed by the healthcare cost savings it generates for payers (French social security and mutual insurance funds), specifically by avoiding hospitalizations, improving quality of life, and delaying dependence. This outcome-based model aligns company revenue with measurable clinical and economic benefits.

satelia.eu
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Reimbursed telemonitoring for heart failure patients via French national health insurance
ModelSubscriptionBilling cadenceMonthly
Notes

Covered at 100% for patients with ticket modérateur exemption; 60% under standard coverage. Operator fee (forfait opérateur) codes: 'TVA' at €11/patient/month (for implantable cardiac prostheses); 'TVB' at €28/patient/month (for heart failure, respiratory, renal insufficiency, diabetes). No device or app installation cost to patients or providers.

satelia.eu
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Télesphore
Description

A paramedical and medical team in direct contact with patients to fight against digital exclusion, providing personalized care journeys regardless of digital proficiency.

satelia.eu
Core offering1 text field

Satelia develops and sells Satelia® Cardio, a Class IIa CE-marked medical device software for remote telemonitoring of chronic heart failure patients. The solution relies on symptom-based questionnaires submitted via web or telephone — no connected devices or app installation required — combined with a proprietary algorithm that detects risk of cardiac decompensation with a 99.43% negative predictive value. The offering is delivered with the Télesphore human care team (nurses, physicians, medical secretaries) that provides direct phone-based support for patients with limited digital skills, and is fully reimbursed by the French national health insurance system.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 36% reduction in all-cause mortality (TELESAT-HF study, 300+ centers, August 2018 – December 2022)
+5 more records
Product overview1 text field

Satelia is a French digital health company offering a unified telemonitoring platform centered on Satelia® Cardio, a Class IIa CE-marked medical device for chronic heart failure patients. The solution comprises a web-based patient monitoring application, the Télesphore human support team (nurses, physicians, medical secretaries), and therapeutic patient education programs. Unlike connected device solutions, Satelia® Cardio relies on symptom questionnaires accessible to all patients regardless of digital literacy, with 77% of patients self-monitoring via internet and 23% assisted by Télesphore nurses. The platform integrates algorithmic risk detection to identify patients at risk of decompensation, supported by coordinated care pathway services.

Product and service3 records
1Satelia® Cardio
CategoryRemote Patient Monitoring Software (Class IIa Medical Device)
Description

A Class IIa CE-marked medical device software (CE 0476) for remote telemonitoring of chronic heart failure patients. Uses symptom-based questionnaires without requiring connected devices, allowing universal access regardless of digital literacy. Delivered to hospitals, clinics, and cardiology practices and prescribed by cardiologists.

2Télesphore
CategoryHuman Care Coordination Service
Description

A paramedical and medical support team (nurses, physicians, medical secretaries) providing direct contact with patients to enable telemonitoring for those with limited digital skills or facing digital exclusion. Delivered as part of the Satelia Cardio service to ensure universal patient coverage (23% of monitored patients are supported via phone by Télesphore nurses).

3Therapeutic Patient Support (ATP)
CategoryTherapeutic Patient Education Service
Description

Individual therapeutic education sessions provided by the Satelia medical team to support patients in managing their heart failure, including patient education, prevention guidance, and care pathway coordination throughout the patient's care journey.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-12-18
Description

Satelia partnered with OVHcloud in December 2024 to migrate its data from a US hosting provider to OVHcloud, a French cloud provider. This move strengthens data sovereignty in the healthcare sector, ensuring data management meets the highest security and privacy standards. The migration supports compliance with French and European healthcare data regulations.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-03-27
Description

Satelia Cardio was integrated into the Resah catalog for healthcare procurement. Resah focuses on pooling and professionalizing purchasing and logistics across healthcare, medical-social, and social sectors, offering Satelia access to its member institutions for telemonitoring solutions.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-08-04
Description

Satelia Cardio was selected by UniHA, the first cooperative network of hospital purchasing in France, in the category of 'Digital Medical Device for Heart Failure Telemonitoring.' This allows NP Medical to submit bids for specific public procurement tenders launched within this category across UniHA's member public healthcare institutions.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

French cardiac remote monitoring platform providing AI-powered analysis of implantable cardiac device data (pacemakers, ICDs). Direct peer to Satelia in the French heart failure telemonitoring space, with overlapping cardiologists and institutional buyers, but differentiated by device-data versus symptom-based approach.

2Biofourmis
TypeDirect peer
Description

Boston/Singapore-based RPM platform with strong heart failure focus and FDA-cleared algorithms. Competes in chronic disease RPM with wearable integration, addressing similar cardiology providers and payer-driven outcomes contracting models as Satelia.

3Health Recovery Solutions
TypeDirect peer
Description

US-based heart failure RPM platform providing tablet-based patient engagement and clinical monitoring. Direct competitor in chronic disease RPM targeting cardiology practices and hospital systems, with comparable patient-reported outcomes workflows.

TypeDirect peer
Description

UK-based digital health platform offering RPM and remote patient management across multiple chronic conditions including heart failure. Comparable regulatory positioning (CE mark, NHS engagement) and provider-facing SaaS business model similar to Satelia's institutional offering.

TypeDirect peer
Description

US-based RPM platform focused on chronic disease management including heart failure, with mobile and tablet-based patient interfaces. Competes for similar hospital and cardiology provider contracts under value-based care arrangements analogous to Satelia's payer-sponsored model.

TypeRegional player
Description

German heart failure telemonitoring provider serving cardiology practices across Germany with comparable symptom-based monitoring workflows. Regional peer addressing similar heart failure cohorts in a different European reimbursement environment, useful as a benchmark for Satelia's potential German expansion.

TypeEmerging player
Description

French connected health device company (Withings) extending into B2B RPM with cellular-connected blood pressure monitors, scales, and sleep trackers for chronic disease management. Comparable French health-tech ecosystem presence with adjacent chronic disease RPM use cases but a device-centric rather than symptom-based approach.

8Doctolib
TypeBroad incumbent
Description

Dominant French health-tech platform for appointment booking, telemedicine, and increasingly patient management. While not a direct RPM competitor, Doctolib's scale and provider relationships in France create potential competitive threat if it extends into chronic disease telemonitoring, and overlaps in serving the same cardiologist customer base.

TypeBroad incumbent
Description

Global medtech incumbent with extensive telehealth, remote monitoring, and population health management offerings including chronic care suites. Broad incumbent providing overlapping capabilities as part of a wider portfolio, targeting hospital systems and cardiology departments similar to Satelia's institutional customers.

TypeEmerging player
Description

Paris-based AI cardiac diagnostics company using deep learning for ECG analysis, recently acquired by Philips. Adjacent French cardiac-AI peer operating in the same cardiology customer base with complementary but distinct functionality (diagnostic AI versus telemonitoring workflows).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Satelia

Remote Patient Monitoring Softwaresatelia.eu

Satelia is a French digital health company operating Satelia® Cardio, a CE-marked Class IIa remote patient monitoring platform for chronic heart failure patients. It combines a symptom-based algorithm with a human nurse support team (Télesphore) to serve 500+ French healthcare providers and 11,000+ patients.

What Satelia does

Satelia is a French digital health company that operates a remote patient monitoring platform purpose-built for chronic heart failure. Its core product, Satelia® Cardio, is a CE-marked Class IIa medical device software that uses structured symptom-based questionnaires — rather than connected devices or wearable sensors — to monitor patients weekly, with results processed by a proprietary algorithm that has demonstrated a 99.43% negative predictive value in identifying low-risk patients in the multicenter TELESAT-HF study. Approximately 77% of monitored patients self-report via a web application, while the remaining 23% are reached by telephone through Télesphore, an in-house paramedical and medical team of nurses, physicians, and medical secretaries that addresses digital exclusion among elderly and non-technophile patients (median patient age 73, over 50% aged 75+).

The company generates revenue via monthly operator fees (forfait opérateur) billed to French healthcare institutions under the national telemonitoring reimbursement framework (Sécurité Sociale), at the TVB rate of €28/patient/month for heart failure. The solution is sold exclusively through institutional channels — hospitals, cardiology practices, and university hospitals — via direct enterprise engagement and through the UniHA and Resah public procurement catalogs. Satelia is trusted by 500+ care providers including approximately one-third of French university hospitals and monitors 11,000+ patients nationwide. Clinical validation includes a 36% reduction in all-cause mortality demonstrated in the TELESAT-HF real-world study and an 87% patient satisfaction rate across 825 monitored patients.

Founded in 2017 by anesthesiologist-intensivist Nicolas Pagès and incorporated as NP Medical (société par actions simplifiée), Satelia is headquartered in Bordeaux. The company raised €10 million from Impact Partners in October 2022 to fund algorithm development and European expansion, obtained CE Class IIa marking in 2025, and has signaled European geographic expansion as a core strategic priority, supported by a December 2024 migration of data hosting to OVHcloud for European data sovereignty.

Satelia firmographics

Firmographics
Name
Satelia
Legal name
NP Medical
Website
https://satelia.eu
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
Satelia is a French digital health company operating Satelia® Cardio, a CE-marked Class IIa remote patient monitoring platform for chronic heart failure patients. It combines a symptom-based algorithm with a human nurse support team (Télesphore) to serve 500+ French healthcare providers and 11,000+ patients.
Ownership category
akta.pro rank

Satelia industry classification

Industry
Product category
Remote Patient Monitoring Software
NAICS
Home Health Care Services (62161), Telephone Call Centers (56142)
SIC
Services-Health Services (8000), Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALABAD
Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALACAB
24/7 Nurse Line, Symptom Checker & Triage (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLACAGAG
Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools

Keywords

  • Remote patient monitoring
  • Heart failure telemonitoring
  • Medical device software
  • Chronic disease management
  • Cardiac care coordination

Where Satelia is headquartered

Location

Headquarters

HQ city
Bordeaux
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Satelia business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Healthcare Reimbursement (French National Health Insurance): Satelia Cardio is reimbursed through the French national health insurance system (Sécurité Sociale). It is covered at 100% for patients with exemption from copayment (ticket modérateur) and at 60% under standard coverage. Specific rates apply for certain special regimes. Revenue is generated through operator fees billed monthly to healthcare facilities under the national telemonitoring framework.
  2. Healthcare Cost Savings (Social Entrepreneurship Model): Satelia is financed by the healthcare cost savings it generates for payers (French social security and mutual insurance funds), specifically by avoiding hospitalizations, improving quality of life, and delaying dependence. This outcome-based model aligns company revenue with measurable clinical and economic benefits.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyReimbursed telemonitoring for heart failure patients via French national health insurance

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Satelia product offering

Product offering

Core offering

Satelia develops and sells Satelia® Cardio, a Class IIa CE-marked medical device software for remote telemonitoring of chronic heart failure patients. The solution relies on symptom-based questionnaires submitted via web or telephone — no connected devices or app installation required — combined with a proprietary algorithm that detects risk of cardiac decompensation with a 99.43% negative predictive value. The offering is delivered with the Télesphore human care team (nurses, physicians, medical secretaries) that provides direct phone-based support for patients with limited digital skills, and is fully reimbursed by the French national health insurance system.

Product overview

Satelia is a French digital health company offering a unified telemonitoring platform centered on Satelia® Cardio, a Class IIa CE-marked medical device for chronic heart failure patients. The solution comprises a web-based patient monitoring application, the Télesphore human support team (nurses, physicians, medical secretaries), and therapeutic patient education programs. Unlike connected device solutions, Satelia® Cardio relies on symptom questionnaires accessible to all patients regardless of digital literacy, with 77% of patients self-monitoring via internet and 23% assisted by Télesphore nurses. The platform integrates algorithmic risk detection to identify patients at risk of decompensation, supported by coordinated care pathway services.

Differentiator

Problem solved

Functional benefit

Brands

  • Télesphore: A paramedical and medical team in direct contact with patients to fight against digital exclusion, providing personalized care journeys regardless of digital proficiency.

Products and services

  • Satelia® Cardio A Class IIa CE-marked medical device software (CE 0476) for remote telemonitoring of chronic heart failure patients. Uses symptom-based questionnaires without requiring connected devices, allowing universal access regardless of digital literacy. Delivered to hospitals, clinics, and cardiology practices and prescribed by cardiologists.
  • Télesphore A paramedical and medical support team (nurses, physicians, medical secretaries) providing direct contact with patients to enable telemonitoring for those with limited digital skills or facing digital exclusion. Delivered as part of the Satelia Cardio service to ensure universal patient coverage (23% of monitored patients are supported via phone by Télesphore nurses).
  • Therapeutic Patient Support (ATP) Individual therapeutic education sessions provided by the Satelia medical team to support patients in managing their heart failure, including patient education, prevention guidance, and care pathway coordination throughout the patient's care journey.

Quantifiable outcome

  • 36% reduction in all-cause mortality (TELESAT-HF study, 300+ centers, August 2018 – December 2022)
  • +5 more outcomes

Companies that use Satelia

Customer profile

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Satelia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Satelia partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • OVHcloudcoreTechnology or Integration · 18 December 2024Satelia partnered with OVHcloud in December 2024 to migrate its data from a US hosting provider to OVHcloud, a French cloud provider. This move strengthens data sovereignty in the healthcare sector, ensuring data management meets the highest security and privacy standards. The migration supports compliance with French and European healthcare data regulations.
  • ResahminorChannel Partner/ Reseller/ Distributor · 27 March 2024Satelia Cardio was integrated into the Resah catalog for healthcare procurement. Resah focuses on pooling and professionalizing purchasing and logistics across healthcare, medical-social, and social sectors, offering Satelia access to its member institutions for telemonitoring solutions.
  • UniHAcoreChannel Partner/ Reseller/ Distributor · 4 August 2023Satelia Cardio was selected by UniHA, the first cooperative network of hospital purchasing in France, in the category of 'Digital Medical Device for Heart Failure Telemonitoring.' This allows NP Medical to submit bids for specific public procurement tenders launched within this category across UniHA's member public healthcare institutions.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Satelia competitors and assessment

Company assessment

Direct peers

  • Implicity: French cardiac remote monitoring platform providing AI-powered analysis of implantable cardiac device data (pacemakers, ICDs). Direct peer to Satelia in the French heart failure telemonitoring space, with overlapping cardiologists and institutional buyers, but differentiated by device-data versus symptom-based approach.
  • Biofourmis: Boston/Singapore-based RPM platform with strong heart failure focus and FDA-cleared algorithms. Competes in chronic disease RPM with wearable integration, addressing similar cardiology providers and payer-driven outcomes contracting models as Satelia.
  • Health Recovery Solutions: US-based heart failure RPM platform providing tablet-based patient engagement and clinical monitoring. Direct competitor in chronic disease RPM targeting cardiology practices and hospital systems, with comparable patient-reported outcomes workflows.
  • Huma (formerly Medopad): UK-based digital health platform offering RPM and remote patient management across multiple chronic conditions including heart failure. Comparable regulatory positioning (CE mark, NHS engagement) and provider-facing SaaS business model similar to Satelia's institutional offering.
  • Vivify Health: US-based RPM platform focused on chronic disease management including heart failure, with mobile and tablet-based patient interfaces. Competes for similar hospital and cardiology provider contracts under value-based care arrangements analogous to Satelia's payer-sponsored model.

Regional players

  • Better@Home (TMM Software): German heart failure telemonitoring provider serving cardiology practices across Germany with comparable symptom-based monitoring workflows. Regional peer addressing similar heart failure cohorts in a different European reimbursement environment, useful as a benchmark for Satelia's potential German expansion.

Emerging players

  • Withings Health Solutions: French connected health device company (Withings) extending into B2B RPM with cellular-connected blood pressure monitors, scales, and sleep trackers for chronic disease management. Comparable French health-tech ecosystem presence with adjacent chronic disease RPM use cases but a device-centric rather than symptom-based approach.
  • Cardiologs (now Philips): Paris-based AI cardiac diagnostics company using deep learning for ECG analysis, recently acquired by Philips. Adjacent French cardiac-AI peer operating in the same cardiology customer base with complementary but distinct functionality (diagnostic AI versus telemonitoring workflows).

Broad incumbents

  • Doctolib: Dominant French health-tech platform for appointment booking, telemedicine, and increasingly patient management. While not a direct RPM competitor, Doctolib's scale and provider relationships in France create potential competitive threat if it extends into chronic disease telemonitoring, and overlaps in serving the same cardiologist customer base.
  • Philips (Connected Care / Population Health): Global medtech incumbent with extensive telehealth, remote monitoring, and population health management offerings including chronic care suites. Broad incumbent providing overlapping capabilities as part of a wider portfolio, targeting hospital systems and cardiology departments similar to Satelia's institutional customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Satelia social profiles

Digital presence

Satelia compliance and trust

Trust signal

Compliance3 records

Satelia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Satelia leadership team

Management profile

Number of profiles

Profiles2 records

Satelia funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Satelia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Satelia

What does Satelia do?

Satelia develops and sells Satelia® Cardio, a Class IIa CE-marked medical device software for remote telemonitoring of chronic heart failure patients. The solution relies on symptom-based questionnaires submitted via web or telephone — no connected devices or app installation required — combined with a proprietary algorithm that detects risk of cardiac decompensation with a 99.43% negative predictive value. The offering is delivered with the Télesphore human care team (nurses, physicians, medical secretaries) that provides direct phone-based support for patients with limited digital skills, and is fully reimbursed by the French national health insurance system.

Is Satelia a public or private company?

Satelia is a private company. It is classified as venture growth investor backed and is currently operating.

When was Satelia founded?

Satelia was founded in 2017. It employs 51 to 100 people.

Where is Satelia based?

Satelia is headquartered in Bordeaux, France, in the Europe region.

How does Satelia make money?

Two revenue lines are on record. Healthcare Reimbursement (French National Health Insurance) is the primary driver. The others are healthcare Cost Savings (Social Entrepreneurship Model).

Who are Satelia's main competitors?

Direct peers on record are Implicity, Biofourmis, Health Recovery Solutions, Huma (formerly Medopad) and Vivify Health. Better@Home (TMM Software) is listed as a regional player. Emerging players are Withings Health Solutions and Cardiologs (now Philips). Broad incumbents are Doctolib and Philips (Connected Care / Population Health).

Does Satelia have an API?

No public API is recorded for Satelia.

What industry is Satelia in?

Satelia's product category is Remote Patient Monitoring Software. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HLALABAD, Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology). Its NAICS code is 62161 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals